Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 4:05 pm Purchase | 2025-10-10 | 13G | Karyopharm Therapeutics Inc. KPTI | Opaleye Management Inc. | 1,569,002 9.480% | 1,569,002 (New Position) | Filing History |
| 2025-10-03 4:05 pm Purchase | 2025-10-01 | 13G | Alpha Cognition Inc. Common Stock ACOG | Opaleye Management Inc. | 1,875,142 8.970% | 1,875,142 (New Position) | Filing History |
| 2025-08-29 4:05 pm Purchase | 2025-08-22 | 13G | Sol-Gel Technologies Ltd. SLGL | Opaleye Management Inc. | 139,386 5.000% | 139,386 (New Position) | Filing History |
| 2025-08-29 4:05 pm Purchase | 2025-08-29 | 13G | Larimar Therapeutics, Inc. LRMR | Opaleye Management Inc. | 4,110,000 4.800% | 157,591 (+3.99%) | Filing History |
| 2025-04-28 4:05 pm Sale | 2025-03-31 | 13G | Protara Therapeutics, Inc. TARA | Opaleye Management Inc. | 1,730,000 4.710% | -95,000 (-5.21%) | Filing History |
| 2025-04-16 5:11 pm Purchase | 2025-04-09 | 13G | Larimar Therapeutics, Inc. LRMR | Opaleye Management Inc. | 3,952,409 6.170% | 2,392,409 (+153.36%) | Filing History |
| 2025-02-14 06:46 am Sale | 2024-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 4,342,500 2.760% | -1,727,500 (-28.46%) | Filing History |
| 2025-02-14 06:42 am Purchase | 2024-12-31 | 13G | iBio, Inc. IBIO | Opaleye Management Inc. | 750,000 7.600% | 100,000 (+15.38%) | Filing History |
| 2025-02-14 06:31 am Purchase | 2024-12-31 | 13G | Protara Therapeutics, Inc. TARA | Opaleye Management Inc. | 1,825,000 5.320% | 143,846 (+8.56%) | Filing History |
| 2025-02-14 06:27 am Sale | 2024-12-31 | 13G | Context Therapeutics Inc. CNTX | Opaleye Management Inc. | 0 0.000% | -820,000 (Position Closed) | Filing History |
| 2024-11-18 06:01 am Purchase | 2024-09-30 | 13G | Protara Therapeutics, Inc. TARA | Opaleye Management Inc. | 1,681,154 8.150% | 1,681,154 (New Position) | Filing History |
| 2024-10-22 7:44 pm Purchase | 2024-10-18 | 13G | SANUWAVE Health, Inc. SNWV | Opaleye Management Inc. | 944,132 11.060% | 944,132 (New Position) | Filing History |
| 2024-09-18 4:50 pm Purchase | 2024-09-17 | 13G | Codexis, Inc. CDXS | Opaleye Management Inc. | 7,524,000 10.610% | 3,984,000 (+112.54%) | Filing History |
| 2024-09-12 4:05 pm Purchase | 2024-09-09 | 13G | Eton Pharmaceuticals, Inc. ETON | Opaleye Management Inc. | 2,722,500 10.340% | 197,613 (+7.83%) | Filing History |
| 2024-07-12 4:15 pm Purchase | 2024-07-03 | 13G | Codexis, Inc. CDXS | Opaleye Management Inc. | 3,540,000 5.020% | 3,540,000 (New Position) | Filing History |
| 2024-04-09 5:22 pm Unchanged | 2024-03-28 | 13G | iBio, Inc. IBIO | Opaleye Management Inc. | 650,000 7.630% | 0 (Unchanged) | Filing History |
| 2024-04-08 8:18 pm Purchase | 2024-03-28 | 13G | iBio, Inc. IBIO | Opaleye Management Inc. | 650,000 7.630% | 650,000 (New Position) | Filing History |
| 2024-02-14 7:48 pm Sale | 2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 6,070,000 5.510% | -5,000 (-0.08%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | SANUWAVE Health, Inc. SNWV | Opaleye Management Inc. | 307,983 9.090% | 224,173 (+267.48%) | Filing History |
| 2024-02-09 4:05 pm Sale | 2023-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | Opaleye Management Inc. | 0 0.000% | -2,810,000 (Position Closed) | Filing History |